Mereo BioPharma Group Plc (MREO)
0.33
0.00 (0.00%)
USD |
NASDAQ |
May 27, 15:45
Mereo BioPharma Group Cash from Financing (Quarterly) : 0.00 for March 31, 2026
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.0094M |
| Autolus Therapeutics Plc | -2.058M |
| Bicycle Therapeutics Plc | -0.0539M |
| DBV Technologies SA | 89.22M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.305M |
| Cash from Investing (Quarterly) | -0.2995M |
| Free Cash Flow | -27.29M |
| Free Cash Flow Per Share (Quarterly) | -0.0287 |
| Free Cash Flow to Equity (Quarterly) | -4.402M |
| Free Cash Flow to Firm (Quarterly) | -4.604M |
| Free Cash Flow Yield | -51.73% |